(Q61883625)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Erika J Sims

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Miranda Mugford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

David Aitken

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jonathan McCormick

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Gita Mehta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Anil Mehta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

UK Cystic Fibrosis Database Steering Committee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

language of work or name

English

0 references

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

9568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1187-1195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

State-of-the-art for DNA technology in newborn screening

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Clinical outcomes of newborn screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Neonatal screening for cystic fibrosis: long-term clinical balance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Newborn screening for cystic fibrosis is associated with reduced treatment intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Demographics of the UK cystic fibrosis population: implications for neonatal screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Genotype and phenotype in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Further comments on fibrosing colonpathy study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous delta F508 controls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Comparison of the clinical manifestations of cystic fibrosis in black and white patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Assessing the cost of cystic fibrosis diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

The cost-effectiveness of neonatal screening for cystic fibrosis: an analysis of alternative scenarios using a decision model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960565-0

7 January 2021

10.1016/S0140-6736(07)60565-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17416263%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference